LISSSD 2025 Bengt Johansson Lindbom
Minervax ApS, SWEDEN, Sweden
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Safety and immunogenicity of a Group B Streptococcus vaccine in participants aged 55-75 years (#177)
5:30 PM
Bengt Johansson Lindbom
Poster Session 1
Vaccinee-derived monoclonal antibodies against GBS highlight functional clusters on the AlpN antigens (#165)
5:30 PM
Wael Bahnan
Poster Session 1